This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Dementia with Lewy bodies (DLB) is characterized clinically by fluctuating cognitive impairment, visual hallucinations, and parkinsonism.1 It is the second most common neurodegenerative disease that causes dementia after AD. The pathologic hallmark of the disease is the presence of Lewy bodies in the cerebral cortex as well as in the brainstem.1 In most cases, numerous senile plaques are also observed in the cerebral cortex, similar to those in the AD brain; neocortical neurofibrillary tangles (NFTs) are rare or absent.2,3 In AD, levels of CSF amyloid β42 (Aβ42) are decreased and levels of CSF tau are increased.4 CSF Aβ42 and tau are thought to be linked with plaques and tangles in the AD brain. Thus, we hypothesized that levels of CSF Aβ42 would be decreased and levels of CSF tau would be normal in DLB. To test this hypothesis we measured levels of CSF Aβ42 …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience
Dr. Henry J. Kaminski and Dr. Sarah Wright
► Watch
Alert Me
Recommended articles
Medial temporal and whole-brain atrophy in dementia with Lewy bodies
Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease